etoposide has been researched along with ganciclovir in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 14 (58.33) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abdel-Moty, SG; Andrei, G; Hayallah, AM; Mohammed, AF; Simons, C; Snoeck, R | 1 |
| Cinatl, J; Doerr, HW; Driever, PH; Kabickova, H; Kornhuber, B; Kotchetkov, R; Schwabe, D; Vogel, JU | 1 |
| Cañete, A; Carvajal, E; Castel, V; Fernández, JM; Verdeguer, A | 1 |
| Hanazono, Y; Ichimura, K; Kanazawa, T; Kitamura, K; Kume, A; Mizukami, H; Nishino, H; Okada, T; Ozawa, K | 1 |
| Oksenhendler, E | 1 |
| Aplan, PD; Cheng, Y; Keenan, B; Nakahara, K; Roschke, AV; Zhang, Z | 1 |
| Fiedler, W; Habermann, RC; Janka-Schaub, GE; Kluge, S; Wolschke, Ch | 1 |
| Achermann, Y; Fehr, J; Lederer, H; Stenner, F; Tinguely, M | 1 |
| Donthireddy, V; Munoz, J; Shareef, N | 1 |
| Doğu, MH; Eren, R; Gündoğan, C; Huq, GE; Kantarci, FE; Suyanı, E | 1 |
| Halliday, M; Ross, J; Southgate, WM | 1 |
| Jin, Z; Wang, J; Wang, Y; Wang, Z; Wu, L; Zhang, J | 1 |
| Bonnabry, P; Fleury-Souverain, S; Guillarme, D; Maurin, J; Rudaz, S | 1 |
2 review(s) available for etoposide and ganciclovir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
HIV-associated multicentric Castleman disease.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Asparaginase; Castleman Disease; Clinical Trials as Topic; Cytarabine; Daunorubicin; Etoposide; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Lymph Nodes; Rituximab; Thioguanine; Valganciclovir; Virus Replication | 2009 |
22 other study(ies) available for etoposide and ganciclovir
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis and anti-HSV activity of tricyclic penciclovir and hydroxybutylguanine derivatives.
Topics: Acyclovir; Antiviral Agents; Guanine; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Models, Molecular | 2019 |
Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells.
Topics: Antigens, Viral; Antineoplastic Agents; Antiviral Agents; Apoptosis; Blotting, Western; Cell Division; Cisplatin; Cytomegalovirus; DNA, Viral; Drug Resistance, Neoplasm; Etoposide; Ganciclovir; Genes, Viral; Humans; Neuroblastoma; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Virus Replication | 1998 |
Herpesvirus-6 encephalitis complicated by Wernicke-Korsakoff syndrome in a pediatric recipient of unrelated cord blood transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Child; Combined Modality Therapy; Cytarabine; Daunorubicin; Encephalitis, Viral; Etoposide; Fatal Outcome; Female; Fetal Blood; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Herpesvirus 6, Human; Humans; Immunocompromised Host; Korsakoff Syndrome; Leukemia, Myeloid, Acute; Recurrence; Roseolovirus Infections; Transplantation Conditioning; Transplantation, Homologous; Virus Activation | 2001 |
Topoisomerase inhibitors enhance the cytocidal effect of AAV-HSVtk/ganciclovir on head and neck cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Survival; Dependovirus; Enzyme Inhibitors; Etoposide; Ganciclovir; Gene Expression; Genes, Transgenic, Suicide; Genetic Therapy; Genetic Vectors; Head and Neck Neoplasms; Humans; Thymidine Kinase; Topoisomerase I Inhibitors | 2004 |
Efficient repair of DNA double-strand breaks in malignant cells with structural instability.
Topics: Antineoplastic Agents, Phytogenic; Antiviral Agents; Blotting, Southern; Chromosome Aberrations; Chromosome Painting; Cinnamates; DNA Breaks, Double-Stranded; DNA Repair; Drug Resistance, Neoplasm; Etoposide; Female; Ganciclovir; Humans; Hygromycin B; In Situ Hybridization, Fluorescence; Ovarian Neoplasms; Peptide Elongation Factor 1; Phosphotransferases (Alcohol Group Acceptor); Plasmids; Promoter Regions, Genetic; Thymidine Kinase; Tumor Cells, Cultured | 2010 |
[28-year old female patient with respiratory insufficiency, elevated liver enzymes, pancytopenia and fever].
Topics: Adult; Antiviral Agents; Bone Marrow Examination; Cyclosporine; Cytokines; Cytomegalovirus Infections; Diagnosis, Differential; Drug Therapy, Combination; Etoposide; Female; Ferritins; Fever of Unknown Origin; Ganciclovir; Humans; Immunosuppressive Agents; Liver Function Tests; Lymphohistiocytosis, Hemophagocytic; Pancytopenia; Pneumonia, Viral; Prednisone; Respiratory Insufficiency; Tomography, X-Ray Computed | 2010 |
Multicentric Castleman's disease as a cause for unclear febrile episodes in a 55-year-old HIV-infected man.
Topics: Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Antiviral Agents; Castleman Disease; Drug Therapy, Combination; Etoposide; Ganciclovir; HIV Infections; Humans; Immunologic Factors; Male; Middle Aged; Rituximab; Seizures, Febrile; Treatment Outcome; Valganciclovir | 2012 |
Cytomegalovirus-induced haemophagocytic lymphohistiocytosis syndrome.
Topics: Cyclosporine; Cytomegalovirus Infections; Dexamethasone; Diagnosis, Differential; Drug Therapy, Combination; Etoposide; Female; Ganciclovir; Humans; Immunoglobulins, Intravenous; Lymphohistiocytosis, Hemophagocytic; Respiration, Artificial; Syndrome; Young Adult | 2012 |
A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination.
Topics: Antiviral Agents; Castleman Disease; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Ganciclovir; Herpesvirus 8, Human; Humans; Male; Middle Aged; Prednisolone; Rituximab; Valganciclovir; Vincristine | 2016 |
Cytomegalovirus-Induced Hemophagocytic Lymphohistiocytosis in an Extreme Preterm Infant: Recognition and Therapy Leading to Recovery.
Topics: Antineoplastic Agents, Phytogenic; Antiviral Agents; Bone Marrow; Cyclosporine; Cytomegalovirus Infections; Dexamethasone; Etoposide; Ganciclovir; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Infant, Extremely Premature; Infant, Newborn; Killer Cells, Natural; Lymphohistiocytosis, Hemophagocytic; Male; Receptors, Interleukin-2; Treatment Outcome; Valganciclovir | 2017 |
Long-term survival benefit of ruxolitinib in a patient with relapsed refractory chronic active Epstein-Barr virus.
Topics: Child; Chronic Disease; DNA, Viral; Drug Resistance, Viral; Epstein-Barr Virus Infections; Etoposide; Fever; Ganciclovir; Herpesvirus 4, Human; Humans; Male; Methylprednisolone; Nitriles; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Recurrence; Splenomegaly; Viral Load; Viremia | 2019 |
Development and application of a liquid chromatography coupled to mass spectrometry method for the simultaneous determination of 23 antineoplastic drugs at trace levels.
Topics: Antineoplastic Agents; Busulfan; Carboplatin; Chromatography, Liquid; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Fluorouracil; Ganciclovir; Humans; Idarubicin; Ifosfamide; Irinotecan; Methanol; Methotrexate; Oxaliplatin; Paclitaxel; Pemetrexed; Tandem Mass Spectrometry; Topotecan; Vinblastine; Vincristine; Water | 2022 |